Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lorch

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Science Advances|February 11, 2026
E7<sub>11-19</sub> placement and orientation dictate CD8<sup>+</sup> T cell response in structurally defined spherical nucleic acid vaccinesJeongmin Hwang, Tonatiuh A Ocampo, Vinzenz Mayer, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Oral Oncology|September 24, 2017
Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapyDanielle N Margalit, Jonathan D Schoenfeld, Bhupendra Rawal, et al.
Frontiers in Medicine|June 26, 2020
Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell CarcinomaGlenn J Hanna, Alec J Kacew, Anusha R Tanguturi, et al.
JCI Insight|February 23, 2018
Frameshift events predict anti-PD-1/L1 response in head and neck cancerGlenn J Hanna, Patrick Lizotte, Megan Cavanaugh, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
Head & Neck|December 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomesKevin Tyan, Ji Eun Bae, Jochen H Lorch, et al.
Histopathology|December 8, 2019
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinomaKristine S Wong, Tiffany Y Chen, Sara E Higgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in <i>BRAF</i> -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Science Advances|February 11, 2026
E7<sub>11-19</sub> placement and orientation dictate CD8<sup>+</sup> T cell response in structurally defined spherical nucleic acid vaccinesJeongmin Hwang, Tonatiuh A Ocampo, Vinzenz Mayer, et al.
Thyroid : Official Journal of the American Thyroid Association|November 4, 2020
Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and OutcomeKristine S Wong, Fei Dong, Milhan Telatar, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Oral Oncology|September 24, 2017
Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapyDanielle N Margalit, Jonathan D Schoenfeld, Bhupendra Rawal, et al.
Frontiers in Medicine|June 26, 2020
Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell CarcinomaGlenn J Hanna, Alec J Kacew, Anusha R Tanguturi, et al.
JCI Insight|February 23, 2018
Frameshift events predict anti-PD-1/L1 response in head and neck cancerGlenn J Hanna, Patrick Lizotte, Megan Cavanaugh, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
Head & Neck|December 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomesKevin Tyan, Ji Eun Bae, Jochen H Lorch, et al.
Histopathology|December 8, 2019
A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinomaKristine S Wong, Tiffany Y Chen, Sara E Higgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in <i>BRAF</i> -Driven Papillary Thyroid Cancer PatientsTheodora Pappa, Sara Ahmadi, Ellen Marqusee, et al.
Pageof 9